Ludovic Bourre, Director of Scientific Engagement for Crown Bio Science gives an overview of the Phase 1 Study of Anti-OX40 in Patients With Metastatic Advanced Cancer and it’s conclusions.
Phase 1 Study of Anti-OX40 in Patients With Metastatic Advanced Cancer
